Effects of Low-level Laser Therapy in the Fatigue Muscle of Healthy Individual and Spastic Individuals

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-09-01

Study Completion Date

2020-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Muscle fatigue is caused by biochemical changes that modify the mechanics of muscle contraction, which result in negative changes in the performance of the contraction. The objective of this study is to evaluate the effects of LLLT on brachial biceps muscle fatigue in healthy individuals and individuals with spastic hemiparesis. The study will consist of three groups (Control Group, Placebo Group and LLLT Group) and all individuals will go through all groups, following the criteria of randomization. The protocol consists of LLLT application in the dominant side brachialis muscle in healthy subjects and on the hemiparetic side of post-stroke individuals, prior to performing the Isometric Maximum Voluntary Contraction (IMVC) for 50 seconds in the isokinetic dynamometer. Will be evaluated pain, myoelectric activity associated with muscular torque, local temperature and blood lactate concentration.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Low Level Laser Therapy in Muscle Fatigue and Muscle Recovery

NCT01844271

Muscle; Fatigue, Heart Skeletal Muscle Recovery

COMPLETED NA

Laser Therapy on Neuromuscular Performance

NCT02813395

Fatigue

COMPLETED NA

Effect of Low-level Laser Therapy on Exercise-induced Muscle Damage

NCT02493556

Muscle Damage

COMPLETED NA

Use of Low-level Laser Therapy (808nm) to Muscle Fatigue Resistance

NCT01972100

Healthy

COMPLETED NA

Study of Effects of Low Level Laser Therapy in the Physical Training and the Muscle Responses in Humans.

NCT01113021

Healthy Young Male Volunteers Non Athletes Free of Metabolic Disease +1 more

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Muscle fatigue is caused by biochemical changes that modify the mechanics of muscle contraction, which result in negative changes in the performance of the contraction. Several resources are studied in order to mitigate this situation, among them we can mention the Low Level-Laser Therapy (LLLT), which has demonstrated positive effects in the treatment of muscle disorders and fatigue prevention. The effects of LLLT are being studied in healthy individuals with fibromyalgia and athletes, currently studies are being performed on spastic muscles with post-stroke patients (post-stroke). The objective of this study is to evaluate the effects of LLLT on brachial biceps muscle fatigue in healthy individuals and individuals with spastic hemiparesis. A double-blind, cross-sectional, comparative, randomized, double-blind clinical trial will be conducted. Phase I will consist of 30 healthy individuals and Phase II will be composed of 30 post-stroke individuals. The study will consist of three groups (Control Group, Placebo Group and LLLT Group) and all individuals will go through all groups, following the criteria of randomization. The protocol consists of LLLT application in the dominant side brachialis muscle in healthy subjects and on the hemiparetic side of post-stroke individuals, prior to performing the Isometric Maximum Voluntary Contraction (IMVC) for 50 seconds in the isokinetic dynamometer. The pain intensity will be evaluated through the Visual Analog Pain Scale, the myoelectric activity through the surface electromyography associated with the evaluation of the muscular torque through the isokinetic dynamometer. The local temperature will be evaluated by infrared thermography and blood lactate concentration by means of the lactimeter, which will be measured at four different times, prior to the application of the laser (basal collection) and 3, 15 and 25 minutes after IMVC.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fatigue Stroke Sequelae

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy group

The protocol consists of Low-level laser therapy (LLLT) application in the dominant side brachialis muscle in healthy subjects prior to performing the Isometric Maximum Voluntary Contraction (IMVC) for 50 seconds in the isokinetic dynamometer and will be analize Visual Analog Pain Scale, electromyography associated with the evaluation of the muscular torque through the isokinetic dynamometer, local infrared thermography and blood lactate concentration by means of the lactimeter, which will be measured at four different times, prior to the application of the laser (basal collection) and 3, 15 and 25 minutes after IMVC. All the participants will pass for three groups: Control group (not will be applicate LLLT), Placebo group (laser will be off) and LLLT group (will be applicate LLLT).

Group Type EXPERIMENTAL

Low-level laser therapy

Intervention Type OTHER

In both arms will be applied Low-level laser therapy and induced muscle fatigue.

Post stroke group

The protocol consists of Low-level laser therapy (LLLT) application in the hemiparetic side brachialis muscle post stroke individuals prior to performing the Isometric Maximum Voluntary Contraction (IMVC) for 50 seconds in the isokinetic dynamometer and will be analize Visual Analog Pain Scale, surface electromyography with the evaluation of the muscular torque through the isokinetic dynamometer, local infrared thermography and blood lactate concentration, which will be measured at four different times, prior to the application of the laser (basal collection) and 3, 15 and 25 minutes after IMVC. All the participants will pass for three groups: Control group (not will be applicate LLLT), Placebo group (laser will be off) and LLLT group (will be applicate LLLT).

Group Type EXPERIMENTAL

Low-level laser therapy

Intervention Type OTHER

In both arms will be applied Low-level laser therapy and induced muscle fatigue.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Low-level laser therapy

In both arms will be applied Low-level laser therapy and induced muscle fatigue.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Preserved cognition, and preservation of the ability to respond to verbal stimul;
* To present the "insufficient active" or "active" indices on the scale of the International Questionnaire of Physical Activity.

* Individuals with medical diagnosis of stroke;
* Individuals with physiotherapeutic diagnosis of spastic hemiparesis with brachial predominance;
* Preserved cognition and preservation of the ability to respond to verbal stimuli;
* Injury time: after 12 months;
* Patients with a maximum of 2 degree spasticity according to the Modified Ashworth Scale and minimum muscle strength of 1 in the biceps brachii muscle.

Exclusion Criteria

* Possess musculoskeletal impairment of the dominant upper limb;
* Practice physical activity with load (bodybuilding);
* Presence of active infection and eruptions in the dominant upper limb;
* Limiting pain that makes it impossible to perform the evaluation protocol;
* Ingestion of analgesic and / or anti-inflammatory drugs and / or drugs containing corticosteroids or steroids.
* Fitzpatrick classification: Phototypes V and VI;
* Presence of malignant neoplastic lesion;
* Presence of active infection and eruptions at the electrode application site;
* Hypoesthesia and / or hyperesthesia and / or anesthesia of the limb in which TLBI will be applied.

* Presence of active infection and eruptions in the dominant upper limb;
* Limiting pain that makes it impossible to perform the evaluation protocol;
* Ingestion of analgesic and / or anti-inflammatory drugs and / or drugs containing corticosteroids or steroids.
* Fitzpatrick classification: Phototypes V and VI;
* Presence of malignant neoplastic lesion;
* Presence of active infection and eruptions at the electrode application site;
* Hypoesthesia and / or hyperesthesia and / or anesthesia of the limb to be treated;
* Muscular contractures and joint deformities;
* Uncontrolled arterial hypertension;
* Individuals with other associated neurological and / or orthopedic disorders;
* Wernick or Broca's aphasia.

Minimum Eligible Age

20 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes